FDA adds warning about vision loss to GLP-1s @WBALTV11
FDA adds warning about vision loss to GLP-1s  @WBALTV11
Uploaded November 2026 | Updated November 2026, 3 hours ago
The FDA will now require makers of GLP-1s like Ozempic and Zepbound to add a warning to their labels about a rare side effect that can cause vision loss potentially associated with the drugs.

Mindy Basara has the latest in today's Medical Minute. Follow updates in the WBAL-TV 11 News app, on WBALTV.com and the link in bio.
FDA adds warning about vision loss to GLP-1sResidents struggle to save damaged garages from fines, demolitionLIVE: Artscape 2027 update: Mainstage headliners - wbaltv.comRavens to debut Darkness Falls jerseys MondayBMore Urbana offers salsa and bachata classes in BaltimoreColder on Friday with a few more showersCake by Jason: Sweets to celebrate the seasonToo soon?Election Night Pizza!Johns Hopkins shares holiday food safety tipsMaryland 2-minute Election RecapInner Harbor Ice Rink opens for winter season
WBAL-TV 11 Baltimore |

FDA adds warning about vision loss to GLP-1s

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER